ACAAI 2022
Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma
The researchers conducted a retrospective cohort study using claims data from the Optum Research Database for 538 patients at least 6 years of age who initiated mepolizumab treatment for asthma between January 2016 and December 2019.